52 related articles for article (PubMed ID: 12621385)
1. Lack of indinavir effects on methadone disposition despite inhibition of hepatic and intestinal cytochrome P4503A (CYP3A).
Kharasch ED; Bedynek PS; Hoffer C; Walker A; Whittington D
Anesthesiology; 2012 Feb; 116(2):432-47. PubMed ID: 22273859
[TBL] [Abstract][Full Text] [Related]
2. The effects of an oral contraceptive containing ethinyloestradiol and norgestrel on CYP3A activity.
Belle DJ; Callaghan JT; Gorski JC; Maya JF; Mousa O; Wrighton SA; Hall SD
Br J Clin Pharmacol; 2002 Jan; 53(1):67-74. PubMed ID: 11849197
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of efavirenz influence on methadone pharmacokinetics and pharmacodynamics.
Kharasch ED; Whittington D; Ensign D; Hoffer C; Bedynek PS; Campbell S; Stubbert K; Crafford A; London A; Kim T
Clin Pharmacol Ther; 2012 Apr; 91(4):673-84. PubMed ID: 22398970
[TBL] [Abstract][Full Text] [Related]
4. Dose-Dependent Pharmacokinetics of Tofacitinib in Rats: Influence of Hepatic and Intestinal First-Pass Metabolism.
Lee JS; Kim SH
Pharmaceutics; 2019 Jul; 11(7):. PubMed ID: 31284540
[TBL] [Abstract][Full Text] [Related]
5. Pupillary unrest, opioid intensity, and the impact of environmental stimulation on respiratory depression.
McKay RE; Kohn MA; Larson MD
J Clin Monit Comput; 2022 Apr; 36(2):473-482. PubMed ID: 33651243
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive combined surrogates of remifentanil blood concentrations with relevance to analgesia.
Lötsch J; Skarke C; Darimont J; Zimmermann M; Bräutigam L; Geisslinger G; Ultsch A; Oertel BG
Naunyn Schmiedebergs Arch Pharmacol; 2013 Oct; 386(10):865-73. PubMed ID: 23775505
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of intravenous and oral alfentanil and pupillary miosis as minimal and noninvasive probes for hepatic and first-pass CYP3A induction.
Kharasch ED; Francis A; London A; Frey K; Kim T; Blood J
Clin Pharmacol Ther; 2011 Jul; 90(1):100-8. PubMed ID: 21562488
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of alfentanil and midazolam in human plasma using liquid chromatography and tandem mass spectrometry.
Kim T; London A; Kharasch ED
J Pharm Biomed Anal; 2011 Jun; 55(3):487-93. PubMed ID: 21382685
[TBL] [Abstract][Full Text] [Related]
9. Concurrent assessment of hepatic and intestinal cytochrome P450 3A activities using deuterated alfentanil.
Kharasch ED; Vangveravong S; Buck N; London A; Kim T; Blood J; Mach RH
Clin Pharmacol Ther; 2011 Apr; 89(4):562-70. PubMed ID: 21346758
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes and management of mechanism-based inhibition of cytochrome P450 3A4.
Zhou S; Chan E; Li X; Huang M
Ther Clin Risk Manag; 2005 Mar; 1(1):3-13. PubMed ID: 18360537
[TBL] [Abstract][Full Text] [Related]
11. Alfentanil-induced miosis as a surrogate measure of alfentanil pharmacokinetics in patients with mild and moderate liver cirrhosis.
Baririan N; Van Obbergh L; Desager JP; Verbeeck RK; Wallemacq P; Starkel P; Horsmans Y
Clin Pharmacokinet; 2007; 46(3):261-70. PubMed ID: 17328584
[TBL] [Abstract][Full Text] [Related]
12. Prediction of cytochrome p450-mediated hepatic drug clearance in neonates, infants and children : how accurate are available scaling methods?
Björkman S
Clin Pharmacokinet; 2006; 45(1):1-11. PubMed ID: 16430308
[TBL] [Abstract][Full Text] [Related]
13. Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs.
Zhou S; Yung Chan S; Cher Goh B; Chan E; Duan W; Huang M; McLeod HL
Clin Pharmacokinet; 2005; 44(3):279-304. PubMed ID: 15762770
[TBL] [Abstract][Full Text] [Related]
14. The effect of quinidine, used as a probe for the involvement of P-glycoprotein, on the intestinal absorption and pharmacodynamics of methadone.
Kharasch ED; Hoffer C; Whittington D
Br J Clin Pharmacol; 2004 May; 57(5):600-10. PubMed ID: 15089813
[TBL] [Abstract][Full Text] [Related]
15. Disposition and miotic effects of oral alfentanil: a potential noninvasive probe for first-pass cytochrome P4503A activity.
Kharasch ED; Hoffer C; Walker A; Sheffels P
Clin Pharmacol Ther; 2003 Mar; 73(3):199-208. PubMed ID: 12621385
[TBL] [Abstract][Full Text] [Related]
16. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis.
Kharasch ED; Walker A; Hoffer C; Sheffels P
Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of intravenous and oral alfentanil and pupillary miosis as minimally invasive and noninvasive probes for hepatic and first-pass CYP3A activity.
Kharasch ED; Walker A; Hoffer C; Sheffels P
J Clin Pharmacol; 2005 Oct; 45(10):1187-97. PubMed ID: 16172184
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]